CD274 and neoplasm: In this study, via microarray assay, we found that tumor cells induced the upregulation of the PD-L1 expression in BMFs by activating the Wnt/β-catenin signaling pathway, providing a potential therapeutic target to overcome the resistance to aPD-L1 immunotherapy in BMFs-rich tumors.